维普中文期刊产品整合服务
12篇 您的检索式:作者名="Duvernoy CS"
    题名 作者 年代 出处 被引量
1Management of cardiogenic shock at- tributable to acute myocardial infarction in the reperfusion era 显示文摘Duvernoy CS Bates ER 2005J Intensive Care Med2005,20,4:1
2Gender differences in adverse outcomes after contemporary percutaneous coronary intervention:an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) percutaneous coronary intervention registry显示文摘Duvernoy CS Smith DE Manohar P 2010Am Heart J2010,159,4:1
3Vascular events in the multiple outcomes of raloxifene evaluation(MORE) trial:incidence,patient characteristics,and effect of raloxifene显示文摘Duvernoy CS Kulkarni PM Dowsett SA 2005Menopause2005,12,4:1
4Gender differences in adverse outcomes after contemporary percutaneous coronary intervention:an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium(BMC2) percutaneous coronary intervention registry显示文摘Duvernoy CS Smith DE Manohar P 2010Am Heart J2010,159,4:1
5Management of cardiogenic shock attributable to acute myocardial infarction in the reperfusion era 显示文摘DUVERNOY CS BATES ER 2005J Intensive Care Med2005,20,4:1
6Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: an analysis from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium(BMC2) percutaneous coronary intervention registry显示文摘Duvernoy CS Smith DE Manohar P 2010Am Heart J2010,159,:1
7Vascular events in the Multiple Outcomes of Raloxifene Evaluation ( MORE ) trial : in- cidence, patient characteristics, and effect of raloxifene显示文摘Duvernoy CS Kulkarni PM Dowsett SA 2005Meno- pause2005,12,4:1
8Genderdifferences in adverse outcomes after contemporary per-cutaneous coronary intervention : an analysis from theBlue Cross Blue Shield of Michigan CardiovascularConsortium ( BMC2 ) percutaneous coronary interven-tion registry 显示文摘Duvernoy CS Smith DE Manohar P 2010Am Heart J2010,159,4:1
9Vascular events in the Multiple Outcomes of Raloxifene Evaluation (MORE) trial: incidence, patient characteristics, and effect of raloxifene 显示文摘Duvernoy CS Kulkarni PM Dowsett SA 2005Menopause2005,12,4:1
10Raloxifene use in clinical practice:efficacy and safety显示文摘Goldstein SR Duvernoy CS Calaf J 2009Menopause2009,16,2:1
11Raloxifene use in clinical practice: Efficacy and safety 显示文摘Goldstein SR Duvernoy CS Calaf J 2009Menopause2009,16,41:1
12How to stay heart healthy in 2011 :con- siderations for the primary prevention of cardiovascular disease in women显示文摘Davis MB Duvernoy CS 2011Womens Health( Lond Engl)2011,7,43:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费